Acute, short-termhyperglycemiaenhancesshear stress–induced platelet activation in patients with type II diabetes mellitus.
Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J.
(1998). BoneuB,CadroyY.Anewmethodforquantifying platelet deposition in ﬂowing native blood in an ex vivo model of human thrombogenesis. Thromb Haemost
(2004). Chemiluminescence and LC-MS/MS analyses for the study of nitric oxide release and distribution following oral administration of nitroaspirin (NCX 4016) in healthy volunteers.
(2007). De MonteP,BonizzoniE.PreventionbyNCX 4016, a nitric oxide-donating aspirin, but not by aspirin, of the acute endothelial dysfunction induced by exercise in patients with intermittent claudication. Thromb Haemost
Direct and irreversible inhibition of cyclooxygenase-1 by nitroaspirin (NCX4016).JPharmacolExpTher2005;
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials.
(2007). Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.
Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs.
(2003). Nesto RW. The platelets in diabetes: focus on prevention of ischemic events. Diabetes Care
(2002). Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ Res
(1992). Nitric oxide functions as an inhibitor of platelet adhesion under ﬂow conditions. Circulation
Pharmacodynamic hybrids coupling established cardiovascular mechanisms of action with additional nitric oxide releasing properties.
(2006). Pharmacologic proﬁle and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders. Cardiovasc Drug Rev
Platelet activation in type 2 diabetes mellitus.
Platelets are essential for leukocyte recruitment in allergic inﬂammation.
Platelets release active matrix metalloproteinase-2 in vivo in humans at a site of vascular injury: lack of inhibition by aspirin.
(2005). Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes
(1996). Reduced effect of aspirin on thrombus formation at high shear and disturbed laminar blood ﬂow. Thromb Haemost
(2008). Resistance to aspirin and thienopyridines in diabetes mellitus and metabolic syndrome. Curr Vasc Pharmacol
(2008). Searching for new NO-donor aspirin-like molecules: a new class of nitrooxy-acyl derivatives of salicylic acid.
Shear stress activation of platelet glycoprotein IIb/IIIa plus von Willebrand factor causes aggregation: ﬁlter blockage and the long bleeding time in von Willebrand’s disease.
The nitric oxide-donating derivative of acetylsalicylic acid, NCX 4016, stimulates glucose transport and glucose transporters translocation in 3T3–L1 adipocytes
(1999). The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care
Von Willebrand factor, type 2 diabetes mellitus, and risk of cardiovascular disease: the Framingham offspring study.